Research Study

A 2-year Prospective Study to Evaluate the Onset of Action of Mavenclad® in Subjects With Highly Active Relapsing Multiple Sclerosis
Principal Investigator 
Robert Carruthers

Overview

Body Locations and Systems 
Multiple Sclerosis
ClinicalTrials.gov# 
NCT03364036
Status 
Recruiting
Study Start/End 
Oct 29, 2018 to Jul 1, 2020
Locations 
UBC Hospital
Name/Title 
Phoebe Allen, Research Nurse
Phone 
604-827-1922
Email Address 
phoebe.allen@ubc.ca
Purpose of Study 

 

The purpose of the study is to determine the onset of Mavenclad® action by frequent magnetic resonance imaging (MRI) assessment of the combined unique active (CUA) lesions in subjects with highly active relapsing multiple sclerosis (RMS).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.